| 1 |
35131711 | Doxorubicin induced aggregation of α-synuclein: Insights into the mechanism of drug induced Parkinsonism. | 2022 Apr |
1 |
| 2 |
35172843 | Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson's disease. | 2022 Feb 16 |
1 |
| 3 |
33275784 | L-DOPA regulates α-synuclein accumulation in experimental parkinsonism. | 2021 Jun |
2 |
| 4 |
34297092 | Dopamine-dependent early synaptic and motor dysfunctions induced by α-synuclein in the nigrostriatal circuit. | 2021 Dec 16 |
1 |
| 5 |
32313102 | α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson's disease. | 2020 Apr 20 |
1 |
| 6 |
32541823 | α-synuclein overexpression in the retina leads to vision impairment and degeneration of dopaminergic amacrine cells. | 2020 Jun 15 |
1 |
| 7 |
32921640 | L-DOPA-Induced Dyskinesia in a Genetic Drosophila Model of Parkinson's Disease. | 2020 Aug 31 |
1 |
| 8 |
31136763 | Temporal changes in neuroinflammation and brain glucose metabolism in a rat model of viral vector-induced α-synucleinopathy. | 2019 Oct |
1 |
| 9 |
31405930 | Female Sex and Brain-Selective Estrogen Benefit α-Synuclein Tetramerization and the PD-like Motor Syndrome in 3K Transgenic Mice. | 2019 Sep 18 |
1 |
| 10 |
29217686 | Synaptic Regulator α-Synuclein in Dopaminergic Fibers Is Essentially Required for the Maintenance of Subependymal Neural Stem Cells. | 2018 Jan 24 |
1 |
| 11 |
29233065 | Understanding the role of glycogen synthase kinase-3 in L-DOPA-induced dyskinesia in Parkinson's disease. | 2018 Jan |
1 |
| 12 |
29907754 | Nano-particle mediated inhibition of Parkinson's disease using computational biology approach. | 2018 Jun 15 |
1 |
| 13 |
30026036 | Deep brain stimulation does not enhance neuroinflammation in multiple system atrophy. | 2018 Oct |
1 |
| 14 |
30357936 | Genotype-phenotype relations for the Parkinson's disease genes SNCA, LRRK2, VPS35: MDSGene systematic review. | 2018 Dec |
1 |
| 15 |
28687316 | Levodopa (L-DOPA) attenuates endoplasmic reticulum stress response and cell death signaling through DRD2 in SH-SY5Y neuronal cells under α-synuclein-induced toxicity. | 2017 Sep 1 |
4 |
| 16 |
26606044 | Levodopa-Induced Motor and Dopamine Receptor Changes in Caenorhabditis elegans Overexpressing Human Alpha-Synuclein. | 2016 |
5 |
| 17 |
26173746 | L-dopa increases α-synuclein DNA methylation in Parkinson's disease patients in vivo and in vitro. | 2015 Nov |
3 |
| 18 |
26306801 | Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation. | 2015 Aug 27 |
2 |
| 19 |
21917769 | Does levodopa accelerate the pathologic process in Parkinson disease brain? | 2011 Oct 11 |
2 |
| 20 |
19409267 | Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons. | 2009 Apr 30 |
1 |
| 21 |
15109582 | Dementia with Lewy bodies and Parkinson's disease. | 2004 May |
1 |
| 22 |
10482268 | Reduced expression of the G209A alpha-synuclein allele in familial Parkinsonism. | 1999 Sep |
1 |
| 23 |
10599788 | PET studies of parkinsonism associated with mutation in the alpha-synuclein gene. | 1999 Dec 10 |
1 |
| 24 |
1899328 | alpha,beta-Dehydro-3,4-dihydroxyphenylalanine derivatives: rate and mechanism of formation. | 1991 Feb 15 |
2 |